Cancer glossary
Paclitaxel: how it is given, why premedication and what to do about numb fingers
Paclitaxel is a chemotherapy drug from the taxane group. Which cancers it treats, weekly and 3-weekly schedules, premedication against allergic reactions and neuropathy.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
Paclitaxel is a chemotherapy drug from the taxane group. It ‘freezes’ the cell's internal scaffolding (microtubules), so the cell cannot divide.
How it appears in your prescription
- ‘Paclitaxel 80 mg/m² weekly × 12’ — often after AC in breast cancer.
- ‘Paclitaxel 175 mg/m² + carboplatin every 3 weeks’ — in ovarian and lung cancer.
- ‘Nab-paclitaxel’ — an albumin-bound form, without that solvent and usually without allergy premedication.
What it means
According to the US National Cancer Institute, paclitaxel is used in breast, ovarian, non-small cell lung, stomach and cervical cancer and other tumors — alone or with platinum drugs and targeted drugs. A blood test is checked before each infusion.
Side effects
Hair loss (almost always), neuropathy — numbness and tingling in the fingers and toes — muscle and joint pain 2–3 days after the infusion, and low neutrophils. Allergic reactions can occur during the infusion.
Tell your doctor about increasing numbness (trouble doing up buttons) or a temperature of 38 °C (100.4 °F) or higher.
Questions to ask your doctor
- Weekly or every 3 weeks — and why?
- What happens if the numbness gets worse?
- Can my hands and feet be cooled during the infusion to reduce neuropathy?
Sources
- Paclitaxel — National Cancer Institute
- Chemotherapy for Breast Cancer — National Cancer Institute
- Carboplatin-Taxol — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
